Rapid tumour lysis syndrome in a metastatic colorectal cancer increased by treatment with irinotecan (CPT-11)

被引:19
作者
Boisseau, M [1 ]
Bugat, R [1 ]
Mahjoubi, M [1 ]
机构
[1] LABS BELLON,NEUILLY SUR SEINE,FRANCE
关键词
D O I
10.1016/0959-8049(95)00654-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:737 / 738
页数:2
相关论文
共 5 条
[1]   CPT-II (IRINOTECAN) IN THE TREATMENT OF COLORECTAL-CANCER [J].
ARMAND, JP ;
DUCREUX, M ;
MAHJOUBI, M ;
ABIGERGES, D ;
BUGAT, R ;
CHABOT, G ;
HERAIT, P ;
DEFORNI, M ;
ROUGIER, P .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (7-8) :1283-1287
[2]  
BARTON JC, 1989, CANCER, V64, P738, DOI 10.1002/1097-0142(19890801)64:3<738::AID-CNCR2820640328>3.0.CO
[3]  
2-Z
[4]   POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF IRINOTECAN (CPT-11) AND ACTIVE METABOLITE SN-38 DURING PHASE-I TRIALS [J].
CHABOT, GG ;
ABIGERGES, D ;
CATIMEL, G ;
CULINE, S ;
DEFORNI, R ;
EXTRA, JM ;
MAHJOUBI, H ;
HERAIT, P ;
ARMAND, JP ;
BUGAT, R ;
CLAVEL, M ;
MARTY, ME .
ANNALS OF ONCOLOGY, 1995, 6 (02) :141-151
[5]   TUMOR LYSIS SYNDROME IN NONHEMATOLOGIC MALIGNANCIES - REPORT OF A CASE AND REVIEW OF THE LITERATURE [J].
DRAKOS, P ;
BARZIV, J ;
CATANE, R .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (06) :502-505